- Program Spotlight:
Personalize Your Cluster Experience and Earn Credits - New Alzheimer’s Drug Spotlights the Importance of Early Detection
- Help Us Pave the Way to a Bolder, Brighter Future for Our Field
- Maintain Your Board Certification or Transfer to Life or Retired Status
- Deliver the Care Experience That Consumers Want and Expect
- Encourage Harmony and Enhance Employee Retention
Program Spotlight:
Personalize Your Cluster Experience and Earn Credits
Escape to Orlando this Dec. 11–13 and enjoy time in the sun while earning up to 24 ACHE Face-to-Face Education credits. Mix and match your education, choosing from seminars like “Workplace Transformation: How to Promote Clinician Wellness and Create a Roadmap for Organizational Change,” “Effective, Credible and Accountable Leadership in the C-suite,” and “Aligning Quality Management and Health Equity to Improve Outcomes.”
Worth six credits each, these three seminars cover many of the pressing issues in the healthcare industry today—how to properly assess and create programs to align equity with reliable and safe care; values-driven leadership and the benefit of embracing compassion and caring as core elements of effective management; and the extent and impact of burnout, building strategies to support clinician wellness.
These sessions can be taken as a group (for a total of 18 ACHE Face-to-Face Education credits) or separately so you can make the most of your time in Florida. Visit ache.org/Orlando to learn more and register.
New Alzheimer’s Drug Spotlights the Importance of Early Detection
The recent approval of the drug Leqembi® (lecanemab) by the U.S. Food and Drug Administration marks a turning point in the treatment of Alzheimer’s disease. It is the first drug approved for Alzheimer’s that reduces amyloid plaques—the sticky clumps of protein in the brain that are thought to contribute to the disease.
Neurology experts agree that for Alzheimer’s, as for other neurodegenerative diseases, early treatment provides the best chance of changing the course of the disease. According to the lecanemab label, physicians should confirm the presence of amyloid prior to beginning treatment and should also perform a genetic test to determine whether the patient is at risk for a rare complication of lecanemab treatment. Both requirements can be met by testing a standard blood sample.
The approval of lecanemab marks the beginning of a new phase in the clinical approach to treating Alzheimer’s. Now that targeting the disease before the onset of symptoms is possible, early detection will play an increasing role in guiding treatment decision-making. For the 500,000 Americans diagnosed with Alzheimer’s every year, this presents a reason to hope for a better future.
For more information about Alzheimer’s disease and dementia testing, visit Alzheimer's and Dementia Testing | Quest Diagnostics.
Quest Diagnostics, an ACHE Premier Corporate Partner, provided the above content.
Help Us Pave the Way to a Bolder, Brighter Future for Our Field
Cultivating leaders who care about equity is at the heart of ACHE’s mission to advance healthcare leadership excellence. To meet the increasingly diverse needs of patients and communities and improve health outcomes, it is critical to help build an inclusive pipeline of talented future healthcare leaders.
ACHE is on a mission to raise $1 million for the Fund for Healthcare Leadership by March 2025. Scholarships from the Fund help diverse, talented individuals acquire the skills and training they need to forge a career path in healthcare leadership. The Fund supports participation in ACHE’s Career Accelerator Program, the Executive Program and the Thomas C. Dolan Executive Diversity Program, as well as additional educational opportunities presented during the year.
Without donor funding, these programs cannot exist, and the need is greater than ever. Please consider a personal gift to the Fund and/or a major gift from your organization to help us achieve our goal of raising $1 million. With your help, we can create a bolder and brighter future in healthcare. Visit ache.org/Fund to learn more about the $1 Million Campaign for Healthcare Leaders of Tomorrow, and make a donation today.
For more information or to discuss gift and pledge options, contact ACHE’s Timothy R. Tlusty, vice president, Development, at ttlusty@ache.org.
Maintain Your Board Certification or Transfer to Life or Retired Status
If you are an ACHE Fellow whose credential is set to expire in 2023, it’s time to recertify by completing these three easy steps:
- Complete a minimum of 36 continuing education credits related to healthcare management and administration (12 must be ACHE Face-to-Face Education credits) OR retake and pass the Board of Governors Exam.
- Complete four volunteer activities, including two that are community/civic-related and two related to healthcare.
- Pay the $200 recertification fee and submit your recertification application by the Dec. 31 deadline.
Learn more about the recertification process by visiting ache.org/FACHE and selecting the Maintain/Recertify My FACHE button from the menu.
If you are over the age of 60 and will retire within the next five years, you may be eligible for a one-time-only, five-year recertification waiver. For more information, please contact Customer Service at (312) 424-9400 or contact@ache.org.
In addition, current Fellows in good standing who are retired from healthcare management may transfer to Retired Status or Life Status. Learn more about the FACHE(R) and LFACHE designations here.
Deliver the Care Experience That Consumers Want and Expect
Healthcare today needs to help people where they are and when they need it. Patient No Longer: Why Healthcare Must Deliver the Care Experience That Consumers Want and Expect explores the industry’s evolving delivery model with a look at the history of patient-centric care and the rise of the healthcare consumer as a powerful new voice.
Authors Ryan Donohue and Stephen Klasko, MD, share how leaders can work to build health systems focused on consumer-centric care and provide actionable ideas for implementation in individual organizations. The ultimate goal is to build a frictionless customer experience that creates lasting connections and builds genuine loyalty.
Order your copy from Health Administration Press today to prepare for this once-in-an-era transformation in healthcare.
Encourage Harmony and Enhance Employee Retention
In a hospital’s fast-paced and high-pressure environment, conflicts among healthcare professionals often arise—and can lead to a decline in employee morale, increased turnover rates and negatively impact the quality of patient care. In an ACHE Blog post, Neal McIntyre, DPA, explores the importance of investing in professional conflict resolution services, which address disagreements in a fair and impartial manner, enabling employees to work toward a resolution and express their concerns without fear of retaliation.
Read about the benefits of conflict resolution services in detail and review steps to effectively prioritize implementation, creating a thriving workplace culture that attracts and retains top talent.